Congratulations to McGowan Institute for Regenerative Medicine
Deputy Director William Wagner, PhD! Dr. Wagner (pictured) was recently elected to the North American Council of the Tissue Engineering and Regenerative Medicine International Society (TERMIS). The Society brings together the international community of persons engaged or interested in the field of tissue engineering and regenerative medicine and promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications, and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies.
Dr. Wagner is also a Professor of Surgery, Bioengineering and Chemical Engineering at the University of Pittsburgh as well as the Director of Thrombosis Research for the Artificial Heart and Lung Program. He is the founding editor of the biomaterials journal Acta Biomaterialia, published by Elsevier, and currently serves on the editorial boards of the Journal of Biomedical Materials Research, Biotechnology and Bioengineering, and the Journal of Tissue Engineering and Regenerative Medicine. In 2006 Dr. Wagner was selected, together with colleague Dr. Michael Sacks, to the "Scientific American 50," the magazine's annual list recognizing leaders in science and technology from the research, business, and policy fields. Dr. Wagner has served as Chairman for the Gordon Research Conference on Biomaterials: Biocompatibility & Tissue Engineering as well as the First World Congress of TERMIS. He has served on numerous NIH and NSF study sections and has been a member of external review committees for national and international organizations focused on bioengineering and regenerative medicine. Dr. Wagner was elected in 2000 as a fellow of the American Institute for Medical and Biological Engineering.
Dr. Wagner's research interests are generally in the area of cardiovascular engineering with projects that address medical device biocompatibility and design, tissue engineering, and targeted imaging. Dr. Wagner and his team enjoy working across the spectrum from in vitro to clinical studies. Researchers within Dr. Wagner's group are afforded the opportunity to observe first-hand the clinical successes and failures of currently employed cardiovascular devices while concurrently working on projects that attempt to describe the current modes of failure, test solutions for the current device shortcomings, or develop technologies that may find application as future cardiovascular therapies.
Illustration: McGowan Institute for Regenerative Medicine.
TERMIS, North America, 2008 Election Results
Bio: Dr. William Wagner